Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Straight Talk About Cancer Drug Coverage

Jan 01 2011

• By Michael McCaughan

Related Content

CMS Takes A Back Seat to No One When it Comes to Drug Safety

Oct 01 2007

ReGen Redux: Does a Troubled Medical Device Review Hold Any Lesson For Drugs?

Oct 01 2009

Dendreon vs. CMS: "Full Coverage" or the CED Solution?

Dec 01 2010

Related Companies

Amgen, Inc.

Johnson & Johnson

Dendreon Corporation

Additional Topics

Regulation Reimbursement Government Payers BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window